We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FENC market cap is 174.91M. The company's latest EPS is USD -0.5871 and P/E is -15.77.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.52M | 9.74M | 25.38M | 7.26M | 6.97M |
| Operating Income | -1.02M | -1.82M | 13.74M | -5.04M | -5.2M |
| Net Income | -1.87M | -2.68M | 12.84M | -5.55M | -5.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 170k | 0 | 1.54M | 21.25M |
| Operating Income | -13.01M | -17.89M | -17.22M | -22.74M | -12.77M |
| Net Income | -12.78M | -18.11M | -17.35M | -23.71M | -16.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.03M | 26.86M | 69.19M | 63.16M | 58.92M |
| Total Liabilities | 29.56M | 38.49M | 66.18M | 64.52M | 64.09M |
| Total Equity | -10.53M | -11.62M | 3.01M | -1.36M | -5.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.15M | 31.42M | 22.41M | 26.94M | 26.86M |
| Total Liabilities | 2.27M | 2.35M | 6.64M | 29.51M | 38.49M |
| Total Equity | 11.88M | 29.07M | 15.77M | -2.57M | -11.62M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.28M | -17.14M | 39.05M | 30.66M | 28.45M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 908k | 6.64M | -1.13M | -875k | -1.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.06M | -15.6M | -14.22M | -18.06M | -17.14M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -71k | 32.29M | 4.98M | 20.73M | 6.64M |
| Market Cap | 174.91M |
| Price to Earnings Ratio | -15.77 |
| Price to Sales Ratio | 11.91 |
| Price to Cash Ratio | 19.07 |
| Price to Book Ratio | -21.77 |
| Dividend Yield | - |
| Shares Outstanding | 27.33M |
| Average Volume (1 week) | 97.6k |
| Average Volume (1 Month) | 56.86k |
| 52 Week Change | -31.91% |
| 52 Week High | 11.49 |
| 52 Week Low | 3.96 |
| Spread (Intraday) | 1.77 (22.04%) |
| Company Name | Fennec Pharmaceuticals Inc |
| Address |
c/o labarge weinstein llp ottawa, ontario K2K 3G4 |
| Website | https://www.fennecpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
